Viewing Study NCT07361094


Ignite Creation Date: 2026-03-26 @ 3:19 PM
Ignite Modification Date: 2026-03-30 @ 3:51 AM
Study NCT ID: NCT07361094
Status: RECRUITING
Last Update Posted: 2026-01-22
First Post: 2026-01-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Autologous CD19/BCMA Dual-Target CAR-T for Relapsed/Refractory Autoimmune Diseases
Sponsor: Beijing Boren Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module